Exhibiting at VIV Asia 2025

Zhejiang Keyland Pharmaceutical Co., Ltd., headquartered in Hangzhou, China, is a prominent pharmaceutical manufacturer and exporter specializing in the production of high-quality veterinary and human medicines. The company focuses on providing effective sulfonamides, anticoccidial drugs, and other pharmaceutical ingredients that meet stringent international standards.

Core Business and Product Offerings

Zhejiang Keyland Pharmaceutical Co., Ltd. is dedicated to manufacturing a broad range of pharmaceutical products designed to enhance animal health, prevent infectious diseases, and treat various human ailments. The company serves the veterinary, agricultural, and healthcare industries globally.

Product Categories

1. Sulfonamides

   • Sulfadimidine: An antibacterial agent used for treating bacterial and protozoal infections in animals.
   • Sulfadiazine: Widely applied in veterinary medicine for the treatment of respiratory and intestinal infections.
   • Sulfamethoxazole: Often used in combination with trimethoprim for treating bacterial infections in both humans and animals.

2. Anticoccidial Drugs

   • Diclazuril: A highly effective anticoccidial agent used to prevent and treat coccidiosis in poultry and other livestock.
   • Toltrazuril: Broad-spectrum anticoccidial widely used for the treatment of protozoan infections in poultry, cattle, and swine.
   • Clopidol: A coccidiostat applied to prevent and control coccidiosis in poultry feed.

3. Veterinary Medicines

   • Florfenicol: A broad-spectrum antibiotic used for the treatment of respiratory and enteric infections in livestock and aquatic animals.
   • Tilmicosin Phosphate: A macrolide antibiotic effective against respiratory diseases in livestock, particularly in poultry and swine.

4. Human Medicines

   • Metronidazole: An antibiotic and antiprotozoal medication used to treat various bacterial infections in humans.
   • Tinidazole: Used for the treatment of bacterial and protozoal infections, particularly those affecting the gastrointestinal and reproductive systems.

Specialization and Unique Selling Proposition (USP)

Zhejiang Keyland Pharmaceutical Co., Ltd. excels in the production of veterinary pharmaceuticals and sulfonamides. Its unique selling propositions include:

• High-Quality Anticoccidials: The company is recognized for its superior quality Diclazuril and Toltrazuril, which are highly effective in preventing coccidiosis in poultry and livestock.
• Comprehensive Product Range: Providing veterinary antibiotics, anticoccidials, and human medicines, serving multiple market segments.
• Research & Development: Continuous innovation to enhance product efficacy and safety.
• Strict Quality Control: Adherence to international GMP standards ensuring the highest level of product quality.
• Global Distribution Network: Well-established market presence across Asia, Europe, North America, and South America.

Financial Performance and Market Reach

Zhejiang Keyland Pharmaceutical Co., Ltd. has established itself as a reliable supplier of veterinary and human medicines. The company’s revenue is primarily driven by the high demand for anticoccidials and veterinary antibiotics in the agricultural sector.

The company has successfully expanded its market presence in Europe, Asia, and the Americas, with a growing demand for products like Diclazuril, Florfenicol, and Tilmicosin Phosphate.

International Shipments Data

The company's export operations are focused on markets with high demand for veterinary medicines and anticoccidial drugs. Major shipment destinations include:

• Asia: Strong demand for sulfonamides and anticoccidial drugs for poultry and livestock.
• Europe: Increasing use of veterinary antibiotics for livestock health and disease prevention.
• North America: Consistent demand for Florfenicol and Tilmicosin Phosphate in the livestock industry.
• South America: Growing market for sulfonamides and human antibiotics.

Certifications and Compliance Records

Zhejiang Keyland Pharmaceutical Co., Ltd. adheres to stringent quality standards and maintains certifications demonstrating its commitment to excellence, including:

• GMP Certification: Ensuring consistent quality and safety of pharmaceutical products.
• ISO9001 Certification: Quality management system compliance for all manufacturing processes.
• FDA Approval: Compliance with the United States Food and Drug Administration requirements for certain products.

These certifications reflect the company's dedication to quality assurance, safety, and customer satisfaction.

Capabilities

The company operates advanced manufacturing facilities with state-of-the-art technology to produce high-quality veterinary and human medicines. Its research and development capabilities enable the company to continuously improve product formulations and enhance manufacturing efficiency.

Zhejiang Keyland Pharmaceutical Co., Ltd. also focuses on providing customized solutions tailored to meet the specific needs of clients worldwide.

Major Achievements

• Recognition as a leading manufacturer of anticoccidial drugs and veterinary antibiotics.
• Continuous growth in revenue driven by successful market penetration in Asia, Europe, and North America.
• Establishment of strategic partnerships with pharmaceutical companies and distributors globally.

Customer Testimonials

The company's products are highly regarded for their effectiveness, quality, and consistency. Customers have praised the company's reliable supply chain and ability to provide customized solutions for various pharmaceutical needs.

Zhejiang Keyland Pharmaceutical Co., Ltd. continues to strengthen its position in the pharmaceutical industry through innovation, adherence to quality standards, and exceptional customer service aimed at meeting the evolving needs of the global market.